State-of-the-art AI model accurately predicting unseen biological experiments X-Cell is trained on X-Atlas/Pisces, the largest and most context-diverse genome-wide perturbation dataset ever reported ...

Rian Hayward is getting noticed as one of the best during the Drag Illustrated Winter Series. Heavy snow warning as 5 feet to strike: 'Blizzard conditions' Screaming child found strapped upside down ...

Jennie Richardson is a TV Features and Lists Writer for Collider, and a graduate student pursuing an MFA in Fiction Writing. In other words, she really loves stories. Editor's Note: The following ...

A new, highly sensitive cell therapy was able to wipe out three different kinds of solid tumors in mice, an important advance in an area where CAR-T cells have long struggled. But significant ...

Let’s say it’s 2036, and scientists are working on a new class of drugs. These medications are mirror-image versions of the molecules your body uses to fight disease. Their big advantage is that ...

Q. You recently wrote that testosterone does not increase the risk for heart attacks. But you overlooked the real risk of testosterone therapy: cancer! I survived advanced prostate cancer seven years ...

Denver’s 9News jokingly introduced a replacement for its longtime host, Kyle Clark. This decision comes after a viewer left feedback on social media, calling for the broadcast to replace Clark and ...

A hip fracture may require hip-replacement surgery for the best outcome, particularly in older patients. Cleveland Clinic Q. Last week, my 81-year-old mother fell breaking her right hip. The ...

The decision removes a chance for the defendants to resolve the long-running case with the death penalty taken off the table. Instead, pretrial hearings are likely to resume. By Carol Rosenberg ...

Researchers at the Max Delbrück Center have found that a cellular housekeeping mechanism called autophagy plays a major role in ensuring that T stem cells undergo normal cell division. The findings, ...

MSK hematologist-oncologist Dr. Lia Palomba led a clinical trial that resulted in FDA approval of lisocabtagene maraleucel (Breyanzi®), a CAR T cell therapy, for marginal zone lymphoma. Marginal zone ...

A laboratory study out of Roswell Park Comprehensive Cancer Center outlines a new way to boost the effectiveness of chimeric antigen receptor (CAR) T-cell therapy in solid-tumor cancers, resulting in ...